Etodolac Tablet, Film Coated
Product Images NDC 71610-859

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 71610-859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 859 30)

Label (71610 859 30)
Etodolac USP 400 mg film-coated tablets in a blister pack of 30 tablets. The label shows storage instructions, barcode, NDC 71610-859-30, manufacturer details (Taro Pharmaceutical, Haifa Bay, Israel, and Aphena Pharma Solutions, Cookeville, TN), and indicates prescription use only.*
FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Etodolac 01)

Chemical Structure (Etodolac 01)
Chemical structure of etodolac, a nonsteroidal anti-inflammatory drug. The diagram shows the molecular framework including a fused bicyclic system with carboxylic acid and ether functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.